skip to main content
Close Icon We use cookies to improve your website experience.  To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy.  By continuing to use the website, you consent to our use of cookies.
Global Search Configuration

Zach McLellan, Jack Allen, and guest analyst Michael Ramirez discuss current events in the healthcare space in the Datamonitor Healthcare Analyst Podcast, including the Novartis purchase of AveXis for $8.7 billion as they target gene therapy in SMA.

Topics covered in this episode include:

  • Novartis purchases AveXis - (AVXS NVS BIIB) - 0:30
  • Results from the ECHO-301 trial of epacadostat in melanoma (INCY NLNK BMY MRK)- 7:37
  • KEYNOTE-042 results of Keytruda in PD-L1 positive NSCLC patients (MRK BMY RHHBY) - 17:24

Subscribe to this podcast here



Next steps

Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.

Request live demo now:

Our team is always happy to hear from you. Please call us at:

  • US Toll-Free   : +1 888 670 8900  
  • US Toll             : +1 212-600-3520
  • UK & Europe : +44 (20) 805 20700
  • Australia        : +61 2 8705 6907

Or please submit your inquiry via the form so that we can provide you the best possible customer service.

Have an immediate and specific information need?

Browse and buy from 1000s of analysis and research reports now: